Phio Pharmaceuticals (PHIO) Cash from Investing Activities (2016 - 2021)
Historic Cash from Investing Activities for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to -$30000.0.
- Phio Pharmaceuticals' Cash from Investing Activities fell 27500.0% to -$30000.0 in Q3 2021 from the same period last year, while for Dec 2021 it was -$51000.0, marking a year-over-year decrease of 16842.11%. This contributed to the annual value of $8000.0 for FY2024, which is 26000.0% up from last year.
- As of Q3 2021, Phio Pharmaceuticals' Cash from Investing Activities stood at -$30000.0, which was down 27500.0% from -$15000.0 recorded in Q2 2021.
- Over the past 5 years, Phio Pharmaceuticals' Cash from Investing Activities peaked at $98000.0 during Q1 2017, and registered a low of -$186000.0 during Q2 2017.
- Its 5-year average for Cash from Investing Activities is -$17857.1, with a median of -$9000.0 in 2020.
- In the last 5 years, Phio Pharmaceuticals' Cash from Investing Activities soared by 20000.0% in 2019 and then crashed by 90000.0% in 2020.
- Phio Pharmaceuticals' Cash from Investing Activities (Quarter) stood at -$15000.0 in 2017, then soared by 66.67% to -$5000.0 in 2018, then surged by 200.0% to $5000.0 in 2019, then tumbled by 120.0% to -$1000.0 in 2020, then crashed by 2900.0% to -$30000.0 in 2021.
- Its Cash from Investing Activities was -$30000.0 in Q3 2021, compared to -$15000.0 in Q2 2021 and -$6000.0 in Q1 2021.